Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
BMC Infect Dis ; 23(1): 584, 2023 Sep 06.
Article in English | MEDLINE | ID: mdl-37674103

ABSTRACT

OBJECTIVE: To estimate the prevalence and risk factors associated with tuberculosis (TB) among people living with human immunodeficiency virus (HIV) infection/acquired immunodeficiency syndrome (AIDS) in China. METHODS: A systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. After the literature was screened based on the inclusion and exclusion criteria, STATA® version 17.0 software was used for the meta-analysis. The heterogeneity among study data was assessed using I2 statistics. Subgroup analysis and meta-regressions were performed to further explore the source of heterogeneity. RESULTS: A total of 5241 studies were retrieved. Of these, 44 studies were found to be eligible. The pooled prevalence of HIV/TB co-infection was 6.0%. The risk factors for HIV/TB co-infection included a low CD4+ T cell count, smoking, intravenous drug use and several other sociodemographic and clinical factors. Bacillus Calmette-Guérin (BCG) vaccination history was a protective factor. CONCLUSION: A high prevalence of TB was observed among people living with HIV/AIDS in China. Low CD4+ T cell count, smoking, and intravenous drug use were the primary risk factors for HIV/TB co-infection, whereas BCG vaccination history was a protective factor. Checking for TB should be prioritized in HIV screening and healthcare access. SYSTEMATIC REVIEW REGISTRATION: Registered on PROSPERO, Identifier: CRD42022297754.


Subject(s)
Acquired Immunodeficiency Syndrome , Coinfection , Tuberculosis , Humans , BCG Vaccine , Coinfection/epidemiology , Prevalence , Risk Factors , Tuberculosis/epidemiology , China/epidemiology
2.
Am J Chin Med ; 51(5): 1189-1209, 2023.
Article in English | MEDLINE | ID: mdl-37314412

ABSTRACT

HIV mutations occur frequently despite the substantial success of combination antiretroviral therapy, which significantly impairs HIV progression. Failure to develop specific vaccines, the occurrence of drug-resistant strains, and the high incidence of adverse effects due to combination antiviral therapy regimens call for novel and safer antivirals. Natural products are an important source of new anti-infective agents. For instance, curcumin inhibits HIV and inflammation in cell culture assays. Curcumin, the principal constituent of the dried rhizomes of Curcuma longa L. (turmeric), is known as a strong anti-oxidant and anti-inflammatory agent with different pharmacological effects. This work aims to assess curcumin's inhibitory effects on HIV in vitro and to explore the underpinning mechanism, focusing on CCR5 and the transcription factor forkhead box protein P3 (FOXP3). First, curcumin and the RT inhibitor zidovudine (AZT) were evaluated for their inhibitory properties. HIV-1 pseudovirus infectivity was determined by green fluorescence and luciferase activity measurements in HEK293T cells. AZT was used as a positive control that inhibited HIV-1 pseudoviruses dose-dependently, with IC50 values in the nanomolar range. Then, a molecular docking analysis was carried out to assess the binding affinities of curcumin for CCR5 and HIV-1 RNase H/RT. The anti-HIV activity assay showed that curcumin inhibited HIV-1 infection, and the molecular docking analysis revealed equilibrium dissociation constants of [Formula: see text]9.8[Formula: see text]kcal/mol and [Formula: see text]9.3[Formula: see text]kcal/mol between curcumin and CCR5 and HIV-1 RNase H/RT, respectively. To examine curcumin's anti-HIV effect and its mechanism in vitro, cell cytotoxicity, transcriptome sequencing, and CCR5 and FOXP3 amounts were assessed at different concentrations of curcumin. In addition, human CCR5 promoter deletion constructs and the FOXP3 expression plasmid pRP-FOXP3 (with an EGFP tag) were generated. Whether FOXP3 DNA binding to the CCR5 promoter was blunted by curcumin was examined using transfection assays employing truncated CCR5 gene promoter constructs, a luciferase reporter assay, and a chromatin immunoprecipitation (ChIP) assay. Furthermore, micromolar concentrations of curcumin inactivated the nuclear transcription factor FOXP3, which resulted in decreased expression of CCR5 in Jurkat cells. Moreover, curcumin inhibited PI3K-AKT activation and its downstream target FOXP3. These findings provide mechanistic evidence encouraging further assessment of curcumin as a dietary agent used to reduce the virulence of CCR5-tropic HIV-1. Curcumin-mediated FOXP3 degradation was also reflected in its functions, namely, CCR5 promoter transactivation and HIV-1 virion production. Furthermore, curcumin inhibition of CCR5 and HIV-1 might constitute a potential therapeutic strategy for reducing HIV progression.


Subject(s)
Curcumin , HIV Infections , HIV-1 , Humans , Curcumin/pharmacology , Curcumin/chemistry , Curcuma/chemistry , HIV-1/genetics , HIV-1/metabolism , HEK293 Cells , Molecular Docking Simulation , Phosphatidylinositol 3-Kinases , Chemokines , HIV Infections/drug therapy , HIV Infections/genetics , Luciferases , Ribonuclease H/pharmacology , Forkhead Transcription Factors/pharmacology , Receptors, CCR5/genetics , Receptors, CCR5/metabolism
3.
Int J Gen Med ; 15: 8353-8363, 2022.
Article in English | MEDLINE | ID: mdl-36465269

ABSTRACT

Coronavirus disease 2019 (COVID-19) remains an uncontained, worldwide pandemic. While battling the disease in China, the Chinese government has actively promoted the use of traditional Chinese medicine, and many studies have been conducted to determine the efficacy of traditional Chinese medicine for treating COVID-19. The present review discusses the effectiveness and safety of traditional Chinese medicine in curing COVID-19 and provides clinical evidence from all confirmed cases in China. Applications of traditional Chinese medicine and specific recipes for treating other viral infections, such as those caused by severe acute respiratory syndrome coronavirus and influenza A viruses (including H1N1), are also discussed. Studies have reported that traditional Chinese medicine treatment plays a significant role in improving clinical symptoms. Therefore, further investigation may be of high translational value in revealing novel targeted therapies for COVID-19.

4.
Environ Technol ; 42(19): 3048-3054, 2021 Aug.
Article in English | MEDLINE | ID: mdl-31969084

ABSTRACT

Simultaneous nitrification and denitrification (SND) were coupled with a denitrifying phosphorus removal (DPR) to achieve simultaneous nutrient and carbon removal. With influent chemical oxygen demand (COD), ammonia-N (NH4+-N), and total phosphorus (TP) concentrations of 250, 50, and 8 mg/L, the SND-DPR coupled system achieved stable nutrient removal efficiency of COD, NH4+-N, TN and TP were 91.8 ± 1.7%, 88.4 ± 1.8%, 64 ± 3.3% and 99.2 ± 0.6%, respectively. Enhancing the C/N ratio strengthened the storage of intracellular polymers and provided sufficient intracellular carbon sources for phosphorus uptake. The nutrient removal efficiency reached the highest level at a C/N ratio of 5, and no advantage was observed after increasing the C/N ratio to 7. Nutrients were mainly removed during the aerobic stage at a low DO concentration as well during the anoxic stage, which helped achieve concurrent nitrification and denitrification by ordinary heterotrophic organisms (OHOs), promote denitrifying and aerobic phosphorus removal, and conserve organic carbon demand and energy consumption for aeration. The system was limited for DO in the aerobic stage at a low DO concentration, resulting in a deficiency in electron acceptors (O2 and NO3-N) and limiting the subsequent promotion of phosphorus uptake and TN removal. The limited DO content in the low DO stage was the key factor involved in enhancing the nutrient removal efficiency along with the increasing influent C/N ratio.


Subject(s)
Nitrification , Phosphorus , Bioreactors , Carbon , Denitrification , Nitrogen , Sewage , Waste Disposal, Fluid , Wastewater
5.
Acta Pharmacol Sin ; 41(4): 546-553, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31685976

ABSTRACT

Increasing levels of plasma urotensin II (UII) are positively associated with atherosclerosis. In this study we investigated the role of macrophage-secreted UII in atherosclerosis progression, and evaluated the therapeutic value of urantide, a potent competitive UII receptor antagonist, in atherosclerosis treatment. Macrophage-specific human UII-transgenic rabbits and their nontransgenic littermates were fed a high cholesterol diet for 16 weeks to induce atherosclerosis. Immunohistochemical staining of the cellular components (macrophages and smooth muscle cells) of aortic atherosclerotic lesions revealed a significant increase (52%) in the macrophage-positive area in only male transgenic rabbits compared with that in the nontransgenic littermates. However, both male and female transgenic rabbits showed a significant decrease (45% in males and 31% in females) in the smooth muscle cell-positive area compared with that of their control littermates. The effects of macrophage-secreted UII on the plaque cellular components were independent of plasma lipid level. Meanwhile the wild-type rabbits were continuously subcutaneously infused with urantide (5.4 µg· kg-1· h-1) using osmotic mini-pumps. Infusion of urantide exerted effects opposite to those caused by UII, as it significantly decreased the macrophage-positive area in male wild-type rabbits compared with that of control rabbits. In cultured human umbilical vein endothelial cells, treatment with UII dose-dependently increased the expression of the adhesion molecules VCAM-1 and ICAM-1, and this effect was partially reversed by urantide. The current study provides direct evidence that macrophage-secreted UII plays a key role in atherogenesis. Targeting UII with urantide may promote plaque stability by decreasing macrophage-derived foam cell formation, which is an indicator of unstable plaque.


Subject(s)
Atherosclerosis/drug therapy , Human Umbilical Vein Endothelial Cells/drug effects , Macrophages/drug effects , Peptide Fragments/pharmacology , Plaque, Atherosclerotic/drug therapy , Urotensins/pharmacology , Animals , Atherosclerosis/metabolism , Atherosclerosis/pathology , Cells, Cultured , Diet, High-Fat/adverse effects , Dose-Response Relationship, Drug , Female , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Infusions, Subcutaneous , Macrophages/metabolism , Male , Peptide Fragments/administration & dosage , Peptide Fragments/blood , Plaque, Atherosclerotic/metabolism , Plaque, Atherosclerotic/pathology , Rabbits , Urotensins/administration & dosage , Urotensins/blood
6.
Chin J Integr Med ; 24(12): 891-896, 2018 Dec.
Article in English | MEDLINE | ID: mdl-28887810

ABSTRACT

OBJECTIVE: To analyze the effect of Chinese medicine (CM) on mortality and quality of life (QOL) of acquired immunodefificiency syndrome (AIDS) patients treated with combined antiretroviral therapy (cART). METHODS: A random sample of AIDS patients enrolled in the National Chinese Medicine Treatment Trial Program (NCMTP) that met the inclusion criteria was included in this study. NCMTP patients were included as the CM+cART group, and those not in the NCMTP were included as the cART group. Survival from September 2004 to September 2012 was analyzed by retrospective cohort study. QOL was analyzed by cross-sectional study. RESULTS: The retrospective cohort study included 528 AIDS patients, 322 in the CM+cART group and 206 in the cART group. After 8 years, the mortality in the CM+cART group was 3.3/100 person-years, which was lower than the cART group of 5.3/100 person-years (P<0.05). The hazard ratio (HR) for mortality in the cART group was 1.6 times that of the CM+cART group by Cox proportional hazard model analysis. After controlling for gender, age, marital status, education, and CD4+ T-cell count, the HR was 1.9 times higher in the cART group compared with the CM+cART group (P<0.05). The cross-sectional study investigated 275 AIDS patients. The mean scores of all QOL domains except spirituality/personal beliefs were higher in the CM+cART group than in the cART group (P<0.05). CONCLUSIONS: For AIDS patients, CM could help to prolong life, decrease mortality, and improve QOL. However, there were limitations in the study, so prospective studies should be carried out to confifirm our primary results.


Subject(s)
Acquired Immunodeficiency Syndrome/drug therapy , Drugs, Chinese Herbal/therapeutic use , Rural Population , Acquired Immunodeficiency Syndrome/mortality , Adult , China/epidemiology , Female , Humans , Male , Quality of Life
7.
Chin J Integr Med ; 23(5): 396-400, 2017 May.
Article in English | MEDLINE | ID: mdl-26142338

ABSTRACT

Moxibustion is an ancient therapeutic technique used in Chinese medicine. Governor Vessel moxibustion (GVM) was developed from long snake moxibustion, a popular technique used in China's Jiangsu and Zhejiang Provinces, and is significantly more effective than general moxibustion. We aimed to review GVM, including its theoretical basis, choices of moxibustion points and materials, operation procedures, clinical applications, and contraindications. This information could increase the appropriate use of GVM and support further in-depth research.


Subject(s)
Medicine, Chinese Traditional , Moxibustion , Fatigue/etiology , Humans , Renal Dialysis/adverse effects
8.
J Virol ; 91(1)2017 Jan 01.
Article in English | MEDLINE | ID: mdl-27795436

ABSTRACT

HIV-1 latency is characterized by reversible silencing of viral transcription driven by the long terminal repeat (LTR) promoter of HIV-1. Cellular and viral factors regulating LTR activity contribute to HIV-1 latency, and certain repressive cellular factors modulate viral transcription silencing. Nef-associated factor 1 (Naf1) is a host nucleocytoplasmic shuttling protein that regulates multiple cellular signaling pathways and HIV-1 production. We recently reported that nuclear Naf1 promoted nuclear export of unspliced HIV-1 gag mRNA, leading to increased Gag production. Here we demonstrate new functions of Naf1 in regulating HIV-1 persistence. We found that Naf1 contributes to the maintenance of HIV-1 latency by inhibiting LTR-driven HIV-1 gene transcription in a nuclear factor kappa B-dependent manner. Interestingly, Naf1 knockdown significantly enhanced viral reactivation in both latently HIV-1-infected Jurkat T cells and primary central memory CD4+ T cells. Furthermore, Naf1 knockdown in resting CD4+ T cells from HIV-1-infected individuals treated with antiretroviral therapy significantly increased viral reactivation upon T-cell activation, suggesting an important role of Naf1 in modulating HIV-1 latency in vivo Our findings provide new insights for a better understanding of HIV-1 latency and suggest that inhibition of Naf1 activity to activate latently HIV-1-infected cells may be a potential therapeutic strategy. IMPORTANCE: HIV-1 latency is characterized mainly by a reversible silencing of LTR promoter-driven transcription of an integrated provirus. Cellular and viral proteins regulating LTR activity contribute to the modulation of HIV-1 latency. In this study, we found that the host protein Naf1 inhibited HIV-1 LTR-driven transcription of HIV genes and contributed to the maintenance of HIV-1 latency. Our findings provide new insights into the effects of host modulation on HIV-1 latency, which may lead to a potential therapeutic strategy for HIV persistence by targeting the Naf1 protein.


Subject(s)
CD4-Positive T-Lymphocytes/metabolism , Gene Expression Regulation, Viral , HIV Infections/genetics , HIV-1/genetics , Ribonucleoproteins/genetics , Virus Latency/genetics , CD4-Positive T-Lymphocytes/virology , Cell Nucleus/metabolism , Cell Nucleus/virology , Gene Silencing , HIV Infections/metabolism , HIV Infections/virology , HIV Long Terminal Repeat , HIV-1/growth & development , HIV-1/metabolism , Host-Pathogen Interactions , Humans , Jurkat Cells , NF-kappa B/genetics , NF-kappa B/metabolism , Primary Cell Culture , Promoter Regions, Genetic , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , RNA, Viral/genetics , RNA, Viral/metabolism , Ribonucleoproteins/antagonists & inhibitors , Ribonucleoproteins/metabolism , Signal Transduction , Transcription, Genetic , Virus Activation , gag Gene Products, Human Immunodeficiency Virus/genetics , gag Gene Products, Human Immunodeficiency Virus/metabolism
9.
Sci Rep ; 6: 34532, 2016 10 04.
Article in English | MEDLINE | ID: mdl-27698388

ABSTRACT

The 5' end of HIV-1 long terminal repeat (LTR) serves as a promoter that plays an essential role in driving viral gene transcription. Manipulation of HIV-1 LTR provides a potential therapeutic strategy for suppressing viral gene expression or excising integrated provirus. Subtype-specific genetic diversity in the LTR region has been observed. The minor variance of LTR, particularly in the transcription factor binding sites, can have a profound impact on its activity. However, the LTR profiles from major endemic Chinese subtypes are not well characterized. Here, by characterizing the sequences and functions of LTRs from endemic Chinese HIV-1 subtypes, we showed that nucleotide variances of Sp1 core promoter and NF-κB element are associated with varied LTR capacity for driving viral gene transcription. The greater responsiveness of Chinese HIV-1 B'-LTR for driving viral gene transcription upon stimulation is associated with an increased level of viral reactivation. Moreover, we demonstrated that the introduction of CRISPR/dead Cas9 targeting Sp1 or NF-κB element suppressed viral gene expression. Taken together, our study characterized LTRs from endemic HIV-1 subtypes in China and suggests a potential target for the suppression of viral gene expression and a novel strategy that facilitates the accomplishment of a functional cure.


Subject(s)
Gene Expression Regulation, Viral/physiology , HIV Long Terminal Repeat , HIV-1 , NF-kappa B/metabolism , Response Elements , Sp1 Transcription Factor/metabolism , China , Female , HEK293 Cells , HIV-1/genetics , HIV-1/metabolism , Humans , Male , NF-kappa B/genetics , Sp1 Transcription Factor/genetics
10.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 36(9): 1128-1131, 2016 Sep.
Article in Chinese | MEDLINE | ID: mdl-30645856

ABSTRACT

HIV/AIDS is a severe infectious disease with ineffective drug or method found till now. Highly active antiretroviral therapy (HAART) is a treatment method widely internationalized. Its coverage populations are continually expanding due to its definite clinical effect. AIDS prevented and treated by Chinese medicine and pharmacy has ever been reported. Especially early intervention of Chinese medicine syndrome differentiation based treatment can delay the process of HIV-infected subjects' entry into AIDS in AIDS asymptomatic phase. However, it has great significance of clinical and basic researches in the following 4 aspects: (1) attenuating toxic/adverse reactions of HAART; (2) improving clinical effects of HAART; (3) lowering resistance rate of HAART; and (4) treating common opportunistic infections of AIDS in the post-HAART period.


Subject(s)
Acquired Immunodeficiency Syndrome , Antiretroviral Therapy, Highly Active , HIV Infections , Medicine, Chinese Traditional , Acquired Immunodeficiency Syndrome/prevention & control , Drugs, Chinese Herbal , HIV , HIV Infections/prevention & control , Humans
11.
Infect Dis Poverty ; 4: 59, 2015 Dec 23.
Article in English | MEDLINE | ID: mdl-26699285

ABSTRACT

Substantial progress has been made in China in using traditional Chinese medicine (TCM) to treat acquired immune deficiency syndrome (AIDS). Our objective was to review the latest developments in TCM treatment of AIDS in China between 2004 and 2014. We reviewed the content of original articles investigating the efficacy and safety of TCM for treating AIDS published in Chinese and English language journals. Relevant references from 2004 to 2014 were found using PubMed and the China National Knowledge Infrastructure Database. We found that TCM has been widely used for treating AIDS and its complications in China. The number of TCM studies has increased, which indicates efficacy and safety. Measures of efficacy in the reviewed articles included the alleviation of human immunodeficiency virus (HIV)-related signs and symptoms, improvements in quality of life, improvements in long-term survival, counteraction of the adverse side effects of antiviral drugs, promotion of immune reconstitution, and improvement of laboratory results. In sum, the literature indicates that TCM is safe. TCM plays an important role in the treatment of AIDS. Some studies have attempted to measure the efficacy and safety of TCM for treating AIDS, but more evidence is needed. Therefore, more research on this topic is required in the future.


Subject(s)
Acquired Immunodeficiency Syndrome/drug therapy , Anti-HIV Agents/therapeutic use , Drugs, Chinese Herbal/therapeutic use , Medicine, Chinese Traditional , Acquired Immunodeficiency Syndrome/history , Acquired Immunodeficiency Syndrome/immunology , Acquired Immunodeficiency Syndrome/mortality , Acquired Immunodeficiency Syndrome/virology , Anti-HIV Agents/administration & dosage , Anti-HIV Agents/adverse effects , CD4 Lymphocyte Count , Drugs, Chinese Herbal/administration & dosage , Drugs, Chinese Herbal/adverse effects , History, 21st Century , Humans , Immunomodulation/drug effects , Medicine, Chinese Traditional/adverse effects , Medicine, Chinese Traditional/history , Medicine, Chinese Traditional/methods , Quality of Life , Treatment Outcome , Viral Load
12.
Chin J Integr Med ; 21(4): 243-8, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25877652

ABSTRACT

Henan Province in China has a major epidemic of human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS). Chinese medicine (CM) has been used throughout the last decade, and a management modality was developed, which can be described by unified-planning, graded-administration, and centralized-controlling (UGC). The UGC modality has one primary concept (patient-centered medicine from CM theory), four basic foundations (classifying administrative region, characteristics of CM on disease treatment, health resource conditions, and distribution of patients living with HIV), six important relationships (the "three uniformities and three combinations," and the six relationships therein guide the treatment of AIDS with CM), and four key sections (management, operation, records, and evaluation). In this article, the authors introduce the UGC modality, which could be beneficial to developing countries or resource-limited areas for the management of chronic infectious disease.


Subject(s)
Acquired Immunodeficiency Syndrome/therapy , Delivery of Health Care/organization & administration , Health Planning Organizations/organization & administration , Medicine, Chinese Traditional , China , HIV Infections/therapy , HIV-1 , Health Plan Implementation/organization & administration , Health Planning/organization & administration , Health Planning Organizations/standards , Humans , Medicine, Chinese Traditional/standards
13.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 34(8): 960-3, 2014 Aug.
Article in Chinese | MEDLINE | ID: mdl-25223181

ABSTRACT

OBJECTIVE: To observe the effect of Qingfei Peiyuan Micro-pill (QPM) on HIV/AIDS patients with pulmonary infection of phlegm heat obstructing lung syndrome (PHOLS). METHODS: Totally 141 HIV/AIDS patients with pulmonary infection of PHOLS were randomly assigned to the treatment group (94 cases) and the control group (47cases). On the basis of Western medicine, patients in the treatment group took QPM. The therapeutic course for all was 28 days. The improvement of symptoms and signs was observed. The body temperature (BT), chest X ray, and white blood cells (WBCs) were detected. RESULTS: The Chinese medical syndrome score was lower in the treatment group than in the control group at the 7th, 21st, and 28th day of treatment, showing statistical difference (P < 0.05). The efficacy was better in the treatment group than in the control group at the 7th, 21st, and 28th day of treatment, showing statistical difference (P < 0.05). The BT was lower in the treatment group than in the control group on the 7th day. There was no statistical difference in the patient number with normal WBCs on the 7th day (P > 0.05). But there was statistical difference in the patient number with normal WBCs on the 14th, 21st, and 28th day of treatment (P < 0.05). There was no statistical difference in the patient number with normal chest X ray on the 7th and 28th day of treatment (P > 0.05). But there was statistical difference in the patient number with normal chest X ray on the 14th and 21 st day of treatment (P < 0.05). CONCLUSION: QPM had certain complementary effect on HIV/AIDS patients with pulmonary infection of PHOLS.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Drugs, Chinese Herbal/therapeutic use , Respiratory Tract Infections/drug therapy , Adult , Female , Humans , Male , Middle Aged , Respiratory Tract Infections/complications , Treatment Outcome
14.
Zhongguo Zhong Yao Za Zhi ; 38(15): 2448-52, 2013 Aug.
Article in Chinese | MEDLINE | ID: mdl-24228533

ABSTRACT

OBJECTIVE: To compare effects of integrated treatment traditional Chinese medicine and Western medicine (TCM-WM) and simple western medicine on TCM clincal symptoms in the patient of AIDS with pulmonary inflammation. METHOD: A multicenter randomized controlled trials of 164 subjects evaluated the effects of clinical symptoms of AIDS with pulmonary inflammation of TWO regimens: the TCM-WM group (n = 111) and western medicine treatment group (n = 53), while incidence of TCM symptoms in different time points in two groups were analyzed. RESULT: Twenty eight days after treatment, the cured and markedly effective rate of TCM symptoms in the TCM-WM group significantly exceeding that in the western medicine treatment group (cured and markedly effective rate significant efficiency 44.55% vs 20.00%), while the incidence rate for the TCM symptoms of fever and headache in the TCM-WM group was significantly lower than that in western medicine group. CONCLUSION: The integrated treatment of traditional Chinese medicine and Western medicine helps to alleviate the TCM clinical symptoms of AIDS with pulmonary inflammation.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Medicine, Chinese Traditional/methods , Pneumonia/complications , Pneumonia/drug therapy , Female , Humans , Male , Multivariate Analysis , Treatment Outcome
15.
Zhongguo Zhong Yao Za Zhi ; 38(15): 2480-3, 2013 Aug.
Article in Chinese | MEDLINE | ID: mdl-24228540

ABSTRACT

OBJECTIVE: Study on quality of life of asymptomatic HIV infected persons with traditional Chinese medical, which can provide the clinical basis for improving the quality of life. METHOD: This study applied a randomized, double-blind, and placeb-parallel control designed method to select 1 200 persons in the asymptomatic period of HIV infection as the subjects. The subjects were randomly divided into the treatment group and the control group at the ratio of about 2:1. According to the results of monthly differential diagnosis of TCM, the test group and the control group were given homologue Chinese drugs preparations and model Chinese drugs. The total study period was 18 months. Using PRO scale and the world health organization AIDS determination of quality of life short scale form (WHOQOL-HIV-BREF) to investigate asymptomatic HIV infected persons, according to different times, we calculated the total score and each domain score of quality of life of the treatment group and control group, we did statistical analysis. RESULT: Form the PRO scale,we can see that the treatment group showed a trend of stability, compared with the control group with significant statistical difference (P < 0.05) after 6 months; from the WHOQOL-HIV scale analysis, we can see that compared with before treatment, the quality of life of the treatment group was increased, the difference was significant (P < 0.05), but the quality of life of the control quality of life was decreased, the differences was significant (P < 0.05). CONCLUSION: Dialectical therapy of Chinese medicine can significantly improve the patient's quality of life, which can provide the basis for the prevention and control policy formulation and implementation with asymptomatic HIV infected persons.


Subject(s)
Asymptomatic Diseases , HIV Infections/therapy , Medicine, Chinese Traditional , Quality of Life , Follow-Up Studies , Humans , Treatment Outcome
16.
Zhongguo Zhong Yao Za Zhi ; 38(15): 2493-6, 2013 Aug.
Article in Chinese | MEDLINE | ID: mdl-24228543

ABSTRACT

OBJECTIVE: Analysis of professor Li Fa-zhi in the treatment of AIDS drug laws of itchy skin, provide the corresponding drug reference basis for Chinese medicine treatment of AIDS, skin itching. METHOD: By using the method of analyzing the complex network of Weishi county, Henan in 2007 October to 2011 July during an interview with professor Li Fa-zhi treatment of AIDS patients with skin pruritus, etiology and pathogenesis analysis, skin itching AIDS syndrome differentiation of old Chinese medicine treatment and medication rule. RESULT: The use of multi-dimensional query analysis, core drug skin itching AIDS treatment in this study as a windbreak, cicada slough, bupleurum, Qufeng solution table drug, licorice detoxification efficacy of drugs, Radix Scutellariae, Kochia scoparia, clearing away heat and promoting diuresis medicine; core prescription for Jingfang San streak virus. CONCLUSION: Professor Li Fa-zhi treatment of AIDS in the skin itching Qufeng solution table dehumidification antipruritic treatment.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Data Mining , Medical Informatics/methods , Medical Records , Medicine, Chinese Traditional/methods , Skin Diseases/complications , Skin Diseases/drug therapy , Humans
17.
Zhongguo Zhong Yao Za Zhi ; 38(15): 2497-500, 2013 Aug.
Article in Chinese | MEDLINE | ID: mdl-24228544

ABSTRACT

OBJECTIVE: Analysis of professor Li Fa-zhi in the treatment of AIDS drug laws of herpes zoster and postherpetic neuralgia, provide reference for the use of Chinese medicine treatment of AIDS, herpes zoster and postherpetic neuralgia. METHOD: By using the method of analyzing the complex network of Weishi county, Henan in 2007 October to 2011 July during an interview with professor Li Fa-zhi treatment of AIDS of herpes zoster and postherpetic neuralgia patients, patients are input structured clinical information collection system, into the analysis of the data, carries on the research analysis theory of traditional Chinese medicine compatibility system algorithm and complex network analysis the use of complex networks. RESULT: The use of multi-dimensional query analysis of AIDS drugs, the core of herpes zoster and postherpetic neuralgia treated in this study are Scutellariae Radix, Glucyrrhizae Radix, Carthame Flos, Plantaginis Semen, Trichosamthis Fructus, Angelicae Sinensis Radix, Gentianae Radix; core prescription for Longdan Xiegan decoction and Trichosanthes red liquorice decoction. CONCLUSION: Professor Li Fa-zhi treatment of AIDS, herpes zoster and postherpetic neuralgia by clearing heat and removing dampness and activating blood circulation to.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Data Mining , Herpes Zoster/complications , Herpes Zoster/drug therapy , Medical Informatics/methods , Medical Records , Medicine, Chinese Traditional/methods , Humans
18.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 33(7): 896-900, 2013 Jul.
Article in Chinese | MEDLINE | ID: mdl-24063208

ABSTRACT

OBJECTIVE: To explore Chinese medicine syndrome distribution laws of asymptomatic HIV infection patients. METHODS: Using Chi-square test, Chinese medicine syndrome distribution laws were compared and analyzed in 1 156 asymptomatic HIV infection patients from March 2009 to October 2011 from four aspects, i.e., age, possible infection time, disease duration, and different routes of infection. RESULTS: Qi deficiency syndrome (QDS) and internal dampness-heat accumulation syndrome (IDHAS) were dominant in all syndrome types. Along with aging, QDS showed a growing tendency, while IDHAS showed obvious declining tendency. There was no obvious change in other syndrome types. There was statistical difference in the distribution of each syndrome type among each age period (P < 0.01). Within 15 years, along with the increase of infection time, QDS showed a growing tendency, while IDHAS ratio showed an obvious declining tendency. No obvious laws were found in other syndrome types. There was statistical difference in the distribution of each syndrome type (P < 0.01). Along with the prolongation of disease duration, the case number of each syndrome showed a decreasing trend, but QDS and IDHAS still accounted for higher ratios in each stage. There was statistical difference in the distribution of each syndrome type (P < 0.01). As for infection routes, QDS was predominant in paid blood donation, blood transfusion infection, intravenous drugs. IDHAS was predominant in sexual transmit. No obvious laws were found in other syndrome types. There was statistical difference in the distribution of each syndrome type (P < 0.01). CONCLUSIONS: DIS, IDHAS, and no confirmable syndrome typing were dominant in asymptomatic HIV infection patients. Deficiency and dampness were important pathological factors for them.


Subject(s)
HIV Infections/diagnosis , Medicine, Chinese Traditional/methods , Adolescent , Adult , Aged , Humans , Middle Aged , Young Adult
19.
Chin J Integr Med ; 19(8): 563-7, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23893134

ABSTRACT

Chinese medicine (CM) has been used in the treatment of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) for 30 years and the demonstrated therapeutic effects of CM, such as reducing plasma HIV viral load, increasing CD4(+)T cell counts, promoting immunity reconstitution, ameliorating symptoms and signs, improving the health related quality of life (HRQOL) and counteracting against the effects of anti-retroviral drugs, were summarized and reviewed in this article. The authors point out that it had been a good opportunity to use CM for the treatment of HIV infection and AIDS in the past and also there are huge challenges ahead for CM research and clinicians to discover more effective CM and its underlying mechanisms for treatment of AIDS.


Subject(s)
Acquired Immunodeficiency Syndrome/therapy , Medicine, Chinese Traditional/methods , Medicine, Chinese Traditional/trends , Acquired Immunodeficiency Syndrome/complications , Antiretroviral Therapy, Highly Active/adverse effects , Antiretroviral Therapy, Highly Active/statistics & numerical data , China , Combined Modality Therapy , Drug-Related Side Effects and Adverse Reactions/drug therapy , Drugs, Chinese Herbal/therapeutic use , Humans , Palliative Care/methods , Quality of Life , Treatment Outcome
20.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 33(11): 1481-4, 2013 Nov.
Article in Chinese | MEDLINE | ID: mdl-24483107

ABSTRACT

OBJECTIVE: To investigate Chinese medical features of acquired immunodeficiency syndrome (AIDS) patients with pulmonary infection. METHODS: Using cluster analysis method, Chinese medical syndromes of 196 AIDS patients with pulmonary infection were analyzed. The distribution features of each syndrome type were analyzed according to the severity and CD4+ numerical analysis. RESULTS: Basic Chinese medical syndrome types could be summed up as three kinds: exterior invasion of wind heat and phlegm heat obstructing Fei syndrome (61 cases, 31.1%), Fei-Pi deficiency and Fei stagnation of phlegm syndrome (64 cases, 32.7%), Fei-Shen deficiency and yin deficiency induced inner heat syndrome (71 cases, 36.2%). There was statistical difference in the severity degree and the distribution of CD4 among the three syndrome types (P < 0.05). CONCLUSIONS: AIDS patients with pulmonary infection involve Fei, Shen, and Pi. The pathogenic factors were related to "wind", "heat", "phlegm", and "xu". The Chinese medical syndrome distribution was closely correlated with patients' immunity.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Acquired Immunodeficiency Syndrome/epidemiology , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/etiology , Acquired Immunodeficiency Syndrome/diagnosis , Adolescent , Adult , Aged , Cluster Analysis , Female , Humans , Male , Medicine, Chinese Traditional/methods , Middle Aged , Respiratory Tract Infections/diagnosis , Yang Deficiency/diagnosis , Yin Deficiency/diagnosis , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...